[Availability of fine needle aspirates for the assessment of HER2 gene amplification in invasive breast cancer patients].

@article{Lee2008AvailabilityOF,
  title={[Availability of fine needle aspirates for the assessment of HER2 gene amplification in invasive breast cancer patients].},
  author={Ji Won Lee and Woo Chul Noh and Min Suk Kim and Hyun-Ah Kim and Yoon Hwan Chang and Young-Joon Hong and Seok‐Il Hong and Jin Kyung Lee},
  journal={The Korean journal of laboratory medicine},
  year={2008},
  volume={28 5},
  pages={
          392-9
        }
}
BACKGROUND FISH and immunohistochemistry (IHC) on formalin-fixed paraffin embedded (FFPE) tissue are currently used in the clinical laboratory to determine HER2 status in invasive breast cancer patients. Since tissue-based methods are relatively time-consuming and have a limitation for standardization of procedure, we evaluated the availability of fine needle aspirates (FNA) for the assessment of HER2 status in invasive breast cancer patients. METHODS FNA were obtained from 51 invasive breast… 
View on PubMed
synapse.koreamed.org
3 Citations

3 Citations

Citation Type

Citation Type

Assessment of Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Breast Carcinoma Using Thin-Prep Cytology Fine Needle Aspiration Cytology FISH Experience From China
TLDR
FNAC is a minimally invasive technique that can be used as an alternative method to collect tissue especially in cases where an excisional or core biopsy is difficult to obtain, or when recurrence is present.
The Effectiveness of Silver In Situ Hybridization in Patients with Breast Cancer: A Systematic Review
TLDR
SISH is a safe and useful test in patients with breast cancer and at least grade D evidence based on existing positive studies and the body of evidence as a whole suggests a Grade D for SISH.
Reliability of immunocytochemistry and fluorescence in situ hybridization on fine‐needle aspiration cytology samples of breast cancers: A comparative study
To characterize breast tumors and metastases, fine‐needle aspiration cytology (FNAB) can be a favorable first choice. However, the diagnostic accuracy of ancillary tests applied to FNAB samples is…

References

SHOWING 1-10 OF 35 REFERENCES
Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with Trastuzumab
TLDR
Her2 status determined by CTA-IHC and FISH are significantly correlated; however, differences between these two assays can a ect patient selection for trastuzumab therapy.
HER-2/neu Detection in Fine-Needle Aspirates of Breast Cancer
TLDR
It is concluded that HER-2 protein expression on cytologic preparations was insufficiently reliable for clinical use, whereas her-2 gene amplification determined by FISH demonstrated strong and consistent correlation with Her-2 status of FFPE tissue samples.
Immunocytochemical evaluation of HER‐2/neu on fine‐needle aspirates from primary breast carcinomas
TLDR
In this study, the false positivity of immunocytochemical technique represents the major criticism and FISH remains the most objective and powerful technique for HER‐2/neu assessment on breast cancer FNAs.
HER-2/neu detection in fine-needle aspirates of breast cancer: fluorescence in situ hybridization and immunocytochemical analysis.
TLDR
It is concluded that HER-2 protein expression on cytologic preparations was insufficiently reliable for clinical use, whereas her-2 gene amplification determined by FISH demonstrated strong and consistent correlation with Her-2 status of FFPE tissue samples.
HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer.
TLDR
Her-2/neu gene amplification can be reliably estimated by FISH on breast cancer FNAs and a good correlation has been found between FISH and IHC results from the corresponding histological sections.
Fluorescence in Situ Hybridization for HER-2/neu Amplification of Breast Carcinoma in Archival Fine Needle Aspiration Biopsy Specimens
TLDR
Her-2/neu amplification status by FISH can be accurately and reliably evaluated in existing archival cytologic slides in archival fine needle aspiration biopsy specimens.
Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry.
  • G. Pauletti, S. Dandekar, +4 authors D. Slamon
  • Medicine, Biology
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2000
TLDR
IHC does not consistently discriminate patients likely to have a poor prognosis, whereas FISH provides superior prognostic information in segregating high-risk from lower-risk beast cancers.
Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.
TLDR
The ability of these antibodies to detect overeexpression was extremely variable, providing an important explantation for the variable overexpression rate reported in the literature.
Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization.
TLDR
Data indicated an excessive sensitivity of the Hercep Test and suggested that, in the case of indeterminate results after standard IHC, the FISH technique is the best approach to establish HER-2 status.
HER-2/neu Evaluation by Fluorescence in Situ Hybridization on Destained Cytologic Smears from Primary and Metastatic Breast Cancer
TLDR
Her-2/neu can be detected by FISH on routinely MGG-stained cytologic slides whenever histologic sections or fresh cytologic material are not available and plays a role in the selection of targeted therapy.
...
1
2
3
4
...